Molecular characterization of rotavirus strains from pre- and post-vaccination periods in a country with low vaccination coverage: The case of Slovenia

Infection, Genetics and Evolution

Volumn 28, Issue , 2014, Pages 413-425

  Steyer, Andrej ^a   Sagadin, Martin ^a   Kolenc, Marko ^a   Poljšak Prijatelj, Mateja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Escape mutants; Group A rotaviruses; Molecular epidemiology; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE; EPITOPE; VIRUS PROTEIN;

ARTICLE; CHILD; FECES ANALYSIS; GENE CLUSTER; GENE SEQUENCE; GENETIC VARIABILITY; HOSPITAL PATIENT; HUMAN; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PREVALENCE; ROTAVIRUS; SLOVENIA; VACCINATION; VIRAL GASTROENTERITIS; VIRUS GENOME; VIRUS STRAIN; AMINO ACID SEQUENCE; CHEMISTRY; CLASSIFICATION; GENETICS; IMMUNOLOGY; INCIDENCE; INFANT; METABOLISM; MOLECULAR GENETICS; NEWBORN; PHYLOGENY; PRESCHOOL CHILD; ROTAVIRUS INFECTIONS; VIROLOGY;

ROTAVIRUS; ROTAVIRUS A;

AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; EPITOPES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SLOVENIA; VIRAL PROTEINS;

EID: 84912532501     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.06.021     Document Type: Article

References (44)

1. Aoki S.T., Settembre E.C., Trask S.D., Greenberg H.B., Harrison S.C., Dormitzer P.R. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 2009, 324:1444-1447.
2. Banyai K., Laszlo B., Duque J., Steele A.D., Nelson E.A., Gentsch J.R., Parashar U.D. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 2012, 30(Suppl. 1):A122-A130.
3. Buttery J.P., Lambert S.B., Grimwood K., Nissen M.D., Field E.J., Macartney K.K., Akikusa J.D., Kelly J.J., Kirkwood C.D. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr. Infect. Dis. J. 2011, 30:S25-S29.
4. Carvalho-Costa F.A., Araujo I.T., Santos de Assis R.M., Fialho A.M., de Assis Martins C.M., Boia M.N., Leite J.P. Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil. Emerg. Infect. Dis. 2009, 15:95-97.
5. Cook N., Bridger J., Kendall K., Gomara M.I., El-Attar L., Gray J. The zoonotic potential of rotavirus. J. Infect. 2004, 48:289-302.
6. Dennehy P.H. Effects of vaccine on rotavirus disease in the pediatric population. Curr. Opin. Pediatr. 2012, 24:76-84.
7. * core. J. Virol. 2002, 76:10512-10517.
8. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B.K., Bhan M.K. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 1992, 30:1365-1373.
9. Gentsch J.R., Laird A.R., Bielfelt B., Griffin D.D., Banyai K., Ramachandran M., Jain V., Cunliffe N.A., Nakagomi O., Kirkwood C.D., Fischer T.K., Parashar U.D., Bresee J.S., Jiang B., Glass R.I. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J. Infect. Dis. 2005, 192(Suppl. 1):S146-S159.
10. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., Fang Z.Y. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J. Clin. Microbiol. 1990, 28:276-282.
11. * antigens in Finland over a 20-year period: no evidence for selection pressure by universal mass vaccination with RotaTeq(R) vaccine. Infect. Genet. Evol. 2013, 19:51-58.
12. Hull J.J., Teel E.N., Kerin T.K., Freeman M.M., Esona M.D., Gentsch J.R., Cortese M.M., Parashar U.D., Glass R.I., Bowen M.D., Surveill N.R.S. United States rotavirus strain surveillance from 2005 to 2008 genotype prevalence before and after vaccine introduction. Pediatr. Infect. Dis. J. 2011, 30:S42-S47.
13. Iturriza-Gomara M., Cubitt D., Steele D., Green J., Brown D., Kang G., Desselberger U., Gray J. Characterisation of rotavirus G9 strains isolated in the UK between 1995 and 1998. J. Med. Virol. 2000, 61:510-517.
14. Iturriza-Gomara M., Dallman T., Banyai K., Bottiger B., Buesa J., Diedrich S., Fiore L., Johansen K., Koopmans M., Korsun N., Koukou D., Kroneman A., Laszlo B., Lappalainen M., Maunula L., Marques A.M., Matthijnssens J., Midgley S., Mladenova Z., Nawaz S., Poljsak-Prijatelj M., Pothier P., Ruggeri F.M., Sanchez-Fauquier A., Steyer A., Sidaraviciute-Ivaskeviciene I., Syriopoulou V., Tran A.N., Usonis V., van Ranst M., de Rougemont A., Gray J. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol. Infect. 2011, 139:895-909.
15. Jain S., Vashistt J., Changotra H. Rotaviruses: is their surveillance needed?. Vaccine 2014, 32:3367-3378.
16. Kirkwood C.D., Boniface K., Barnes G.L., Bishop R.F. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix(R) and RotaTeq(R), into the National Immunization Program of Australia. Pediatr. Infect. Dis. J. 2011, 30:S48-S53.
17. Leite J.P., Carvalho-Costa F.A., Linhares A.C. Group A rotavirus genotypes and the ongoing Brazilian experience: a review. Mem. Inst. Oswaldo Cruz 2008, 103:745-753.
18. Lopman B.A., Payne D.C., Tate J.E., Patel M.M., Cortese M.M., Parashar U.D. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Curr. Opin. Virol. 2012, 2:434-442.
19. Martella V., Banyai K., Matthijnssens J., Buonavoglia C., Ciarlet M. Zoonotic aspects of rotaviruses. Vet. Microbiol. 2010, 140:246-255.
20. Matthijnssens J., Ciarlet M., McDonald S.M., Attoui H., Banyai K., Brister J.R., Buesa J., Esona M.D., Estes M.K., Gentsch J.R., Iturriza-Gomara M., Johne R., Kirkwood C.D., Martella V., Mertens P.P.C., Nakagomi O., Parreno V., Rahman M., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Patton J.T., Desselberger U., Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol. 2011, 156:1397-1413.
21. Matthijnssens J., Ciarlet M., Rahman M., Attoui H., Banyai K., Estes M.K., Gentsch J.R., Iturriza-Gomara M., Kirkwood C.D., Martella V., Mertens P.P.C., Nakagomi O., Patton J.T., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Desselberger U., Van Ranst M. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch. Virol. 2008, 153:1621-1629.
22. Matthijnssens J., Heylen E., Zeller M., Rahman M., Lemey P., Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol. Biol. Evol. 2010, 27:2431-2436.
23. Matthijnssens J., Nakagomi O., Kirkwood C.D., Ciarlet M., Desselberger U., Van Ranst M. Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?. Expert Rev. Vaccines 2012, 11:1347-1354.
24. Matthijnssens J., Van Ranst M. Genotype constellation and evolution of group A rotaviruses infecting humans. Curr. Opin. Virol. 2012, 2:426-433.
25. McDonald S.M., Davis K., McAllen J.K., Spiro D.J., Patton J.T. Intra-genotypic diversity of archival G4P[8] human rotaviruses from Washington, DC. Infect. Genet. Evol. 2011, 11:1586-1594.
26. Msimang V.M., Page N., Groome M.J., Moyes J., Cortese M.M., Seheri M., Kahn K., Chagan M., Madhi S.A., Cohen C. Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program. Pediatr. Infect. Dis. J. 2013, 32:1359-1364.
27. Papp H., Borzak R., Farkas S., Kisfali P., Lengyel G., Molnar P., Melegh B., Matthijnssens J., Jakab F., Martella V., Banyai K. Zoonotic transmission of reassortant porcine G4P[6] rotaviruses in Hungarian pediatric patients identified sporadically over a 15 year period. Infect. Genet. Evol. 2013, 19:71-80.
28. Parashar U.D., Gibson C.J., Bresee J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis. 2006, 12:304-306.
29. Paulke-Korinek M., Kollaritsch H., Aberle S.W., Zwazl I., Schmidle-Loss B., Vecsei A., Kundi M. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine 2013, 31:2686-2691.
30. Payne D.C., Boom J.A., Staat M.A., Edwards K.M., Szilagyi P.G., Klein E.J., Selvarangan R., Azimi P.H., Harrison C., Moffatt M., Johnston S.H., Sahni L.C., Baker C.J., Rench M.A., Donauer S., McNeal M., Chappell J., Weinberg G.A., Tasslimi A., Tate J.E., Wikswo M., Curns A.T., Sulemana I., Mijatovic-Rustempasic S., Esona M.D., Bowen M.D., Gentsch J.R., Parashar U.D. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin. Infect. Dis. 2013, 57:13-20.
31. Rasanen S., Lappalainen S., Halkosalo A., Salminen M., Vesikari T. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination. Scand. J. Infect. Dis. 2011, 43:58-63.
32. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., Cheuvart B., Espinoza F., Gillard P., Innis B.L., Cervantes Y., Linhares A.C., Lopez P., Macias-Parra M., Ortega-Barria E., Richardson V., Rivera-Medina D.M., Rivera L., Salinas B., Pavia-Ruz N., Salmeron J., Ruttimann R., Tinoco J.C., Rubio P., Nunez E., Guerrero M.L., Yarzabal J.P., Damaso S., Tornieporth N., Saez-Llorens X., Vergara R.F., Vesikari T., Bouckenooghe A., Clemens R., De Vos B., O'Ryan M. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 2006, 354:11-22.
33. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 2005, 15:29-56.
34. Standaert B., Gomez J.A., Raes M., Debrus S., Velazquez F.R., Postma M.J. Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed data. PLoS One 2013, 8:e53864.
35. Steyer A., Poljsak-Prijatelj M., Barlic-Maganja D., Bufon T., Marin J. The emergence of rotavirus genotype G9 in hospitalised children in Slovenia. J. Clin. Virol. 2005, 33:7-11.
36. Steyer A., Poljsak-Prijatelj M., Barlic-Maganja D., Marin J. Human, porcine and bovine rotaviruses in Slovenia: evidence of interspecies transmission and genome reassortment. J. Gen. Virol. 2008, 89:1690-1698.
37. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
38. Trask S.D., McDonald S.M., Patton J.T. Structural insights into the coupling of virion assembly and rotavirus replication. Nat. Rev. Microbiol. 2012, 10:165-177.
39. Trimis G., Koutsoumbari I., Kottaridi C., Palaiologou N., Assimakopoulou E., Spathis A., Lebessi E., Konstantopoulos A., Kafetzis D., Karakitsos P., Papaevangelou V. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector. Vaccine 2011, 29:7292-7295.
40. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., Dallas M.J., Heyse J.F., Goveia M.G., Black S.B., Shinefield H.R., Christie C.D., Ylitalo S., Itzler R.F., Coia M.L., Onorato M.T., Adeyi B.A., Marshall G.S., Gothefors L., Campens D., Karvonen A., Watt J.P., O'Brien K.L., DiNubile M.J., Clark H.F., Boslego J.W., Offit P.A., Heaton P.M. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 2006, 354:23-33.
41. Vesikari T., Uhari M., Renko M., Hemming M., Salminen M., Torcel-Pagnon L., Bricout H., Simondon F. Impact and effectiveness of RotaTeq(R) vaccine based on three years of surveillance following introduction of a rotavirus immunization program in Finland. Pediatr. Infect. Dis. J. 2013, 32:1365-1367.
42. Werle E., Schneider C., Renner M., Volker M., Fiehn W. Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Res. 1994, 22:4354-4355.
43. Zeller M., Patton J.T., Heylen E., De Coster S., Ciarlet M., Van Ranst M., Matthijnssens J. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J. Clin. Microbiol. 2012, 50:966-976.
44. Zeller M., Rahman M., Heylen E., De Coster S., De Vos S., Arijs I., Novo L., Verstappen N., Van Ranst M., Matthijnssens J. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010, 28:7507-7513.